Soleus Capital Master Fund, L.P. 13D and 13G filings for Theratechnologies Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:14 am Purchase | 2022-12-31 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 2,587,281 10.700% | 168,304 (+6.96%) | Filing |
| 2022-11-14 5:00 pm Purchase | 2022-11-11 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 2,418,977 10.010% | 108,457 (+4.69%) | Filing |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 2,310,521 9.600% | 454,175 (+24.47%) | Filing |
| 2021-02-23 4:11 pm Purchase | 2021-01-19 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 1,856,346 7.800% | 1,856,346 (New Position) | Filing |